Literature DB >> 18184799

On BC1 RNA and the fragile X mental retardation protein.

Anna Iacoangeli1, Timofey S Rozhdestvensky, Natalia Dolzhanskaya, Barthélémy Tournier, Janin Schütt, Jürgen Brosius, Robert B Denman, Edouard W Khandjian, Stefan Kindler, Henri Tiedge.   

Abstract

The fragile X mental retardation protein (FMRP), the functional absence of which causes fragile X syndrome, is an RNA-binding protein that has been implicated in the regulation of local protein synthesis at the synapse. The mechanism of FMRP's interaction with its target mRNAs, however, has remained controversial. In one model, it has been proposed that BC1 RNA, a small non-protein-coding RNA that localizes to synaptodendritic domains, operates as a requisite adaptor by specifically binding to both FMRP and, via direct base-pairing, to FMRP target mRNAs. Other models posit that FMRP interacts with its target mRNAs directly, i.e., in a BC1-independent manner. Here five laboratories independently set out to test the BC1-FMRP model. We report that specific BC1-FMRP interactions could be documented neither in vitro nor in vivo. Interactions between BC1 RNA and FMRP target mRNAs were determined to be of a nonspecific nature. Significantly, the association of FMRP with bona fide target mRNAs was independent of the presence of BC1 RNA in vivo. The combined experimental evidence is discordant with a proposed scenario in which BC1 RNA acts as a bridge between FMRP and its target mRNAs and rather supports a model in which BC1 RNA and FMRP are translational repressors that operate independently.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184799      PMCID: PMC2206605          DOI: 10.1073/pnas.0710991105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Characterization of Staufen 1 ribonucleoprotein complexes.

Authors:  Cornelia Brendel; Monika Rehbein; Hans-Jürgen Kreienkamp; Friedrich Buck; Dietmar Richter; Stefan Kindler
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in vitro translation systems is reversed by poly(A)-binding protein (PABP).

Authors:  Alexander V Kondrashov; Martin Kiefmann; Klaus Ebnet; Tasneem Khanam; Ravi Sondekoppa Muddashetty; Jürgen Brosius
Journal:  J Mol Biol       Date:  2005-10-14       Impact factor: 5.469

Review 3.  RNA transport and local control of translation.

Authors:  Stefan Kindler; Huidong Wang; Dietmar Richter; Henri Tiedge
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

4.  RNA reigns in neurons.

Authors:  Henri Tiedge
Journal:  Neuron       Date:  2005-10-06       Impact factor: 17.173

5.  CLIP: a method for identifying protein-RNA interaction sites in living cells.

Authors:  Jernej Ule; Kirk Jensen; Aldo Mele; Robert B Darnell
Journal:  Methods       Date:  2005-12       Impact factor: 3.608

6.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

Authors:  I J Weiler; S A Irwin; A Y Klintsova; C M Spencer; A D Brazelton; K Miyashiro; T A Comery; B Patel; J Eberwine; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

7.  Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes.

Authors:  Jennifer C Darnell; Claire E Fraser; Olga Mostovetsky; Giovanni Stefani; Thomas A Jones; Sean R Eddy; Robert B Darnell
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

8.  Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells.

Authors:  Giovanni Stefani; Claire E Fraser; Jennifer C Darnell; Robert B Darnell
Journal:  J Neurosci       Date:  2004-08-18       Impact factor: 6.167

9.  The fragile X mental retardation protein has nucleic acid chaperone properties.

Authors:  Caroline Gabus; Rachid Mazroui; Sandra Tremblay; Edouard W Khandjian; Jean-Luc Darlix
Journal:  Nucleic Acids Res       Date:  2004-04-19       Impact factor: 16.971

10.  Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif.

Authors:  Francesca Zalfa; Salvatore Adinolfi; Ilaria Napoli; Eva Kühn-Hölsken; Henning Urlaub; Tilmann Achsel; Annalisa Pastore; Claudia Bagni
Journal:  J Biol Chem       Date:  2005-07-08       Impact factor: 5.157

View more
  49 in total

1.  Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.

Authors:  Farr Niere; Julia R Wilkerson; Kimberly M Huber
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

Review 2.  The state of synapses in fragile X syndrome.

Authors:  Brad E Pfeiffer; Kimberly M Huber
Journal:  Neuroscientist       Date:  2009-03-26       Impact factor: 7.519

Review 3.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

4.  Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.

Authors:  Lei Nie; Hsing-Ju Wu; Jung-Mao Hsu; Shih-Shin Chang; Adam M Labaff; Chia-Wei Li; Yan Wang; Jennifer L Hsu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2012-04-08       Impact factor: 4.060

5.  Dendritic mRNA targeting of Jacob and N-methyl-d-aspartate-induced nuclear translocation after calpain-mediated proteolysis.

Authors:  Stefan Kindler; Daniela C Dieterich; Janin Schütt; Jale Sahin; Anna Karpova; Marina Mikhaylova; Claudia Schob; Eckart D Gundelfinger; Hans-Jürgen Kreienkamp; Michael R Kreutz
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

6.  On BC1 RNA and the fragile X mental retardation protein.

Authors:  Claudia Bagni
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-15       Impact factor: 11.205

7.  Reply to Bagni: On BC1 RNA and the fragile X mental retardation protein.

Authors:  Anna Iacoangeli; Timofey S Rozhdestvensky; Natalia Dolzhanskaya; Barthélémy Tournier; Janin Schütt; Jürgen Brosius; Robert B Denman; Edouard W Khandjian; Stefan Kindler; Henri Tiedge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

Review 8.  The function of activity-regulated genes in the nervous system.

Authors:  Sven Loebrich; Elly Nedivi
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

Review 9.  Aβ oligomer-induced synapse degeneration in Alzheimer's disease.

Authors:  Kyle C Wilcox; Pascale N Lacor; Jason Pitt; William L Klein
Journal:  Cell Mol Neurobiol       Date:  2011-05-03       Impact factor: 5.046

Review 10.  Translational control of long-lasting synaptic plasticity and memory.

Authors:  Mauro Costa-Mattioli; Wayne S Sossin; Eric Klann; Nahum Sonenberg
Journal:  Neuron       Date:  2009-01-15       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.